" class="no-js "lang="en-US"> Maria Palasis - Medtech Alert
Friday, June 20, 2025
Maria Palasis

Maria Palasis

About Maria Palasis

Maria Palasis has served as Lyra’s President and Chief Executive Officer and a member of its board of directors since January 2015. Previously, Dr. Palasis held positions of increasing responsibility, the most recent of which was Executive Vice President and Chief Technology Officer from 2011 to 2015. Before that, in 2008, Dr. Palasis joined Arsenal Medical, Inc., a biotechnology company, as Executive Vice President and subsequently served as President and Chief Executive Officer, and a member of the board of directors of Arsenal Medical from January 2015 to June 2018. Prior to that, Dr. Palasis served as Director at Boston Scientific Corporation, a medical device company, where she managed a portfolio of external biotech and medical device investments and led the development of several combination therapies. Dr. Palasis holds a B.S. and Ph.D. in Chemical Engineering from the University of Cincinnati, and she held a postdoctoral fellowship in molecular biology at the University of Cincinnati School of Medicine.

Related Story

Lyra Therapeutics Announces Appointment of Richard Nieman, MD, as Chief Medical Officer

July 6 2022

Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable […]